Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YI
3151
111 Inc
YI
$33.3M
| $119K | ﹤0.01% |
11,215
-224
| -2% | -$2.53K |
|
3152
Beasley Broadcasting Group
BBGI
$39.3M
| $119K | ﹤0.01% |
9,076
-620
| -6% | -$8.66K |
|
3153
Sono-Tek
SOTK
$82M
| $119K | ﹤0.01% |
30,800
+2,400
| +8% | +$10.8K |
|
|
VIRX
3154
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $118K | ﹤0.01% |
217,699
+15,200
| +8% | +$12K |
|
3155
Achieve Life Sciences
ACHV
$744M
| $118K | ﹤0.01% |
25,060
+14,360
| +134% | +$69.2K |
|
3156
Team
TISI
$101M
| $118K | ﹤0.01% |
+13,251
| New | +$101K |
|
3157
Generation Income Properties
GIPR
$762K
| $117K | ﹤0.01% |
+2,860
| New | +$116K |
|
3158
Asia Pacific Wire & Cable
APWC
$61.8M
| $116K | ﹤0.01% |
73,200
+200
| +0.3% | +$294 |
|
3159
CPS Technologies
CPSH
$83M
| $116K | ﹤0.01% |
68,247
-17,545
| -20% | -$30.9K |
|
3160
Pluri
PLUR
$17.5M
| $116K | ﹤0.01% |
20,025
-14,362
| -42% | -$81K |
|
|
TWOU
3161
DELISTED
2U Inc
TWOU
| $115K | ﹤0.01% |
22,489
-6,584
| -23% | -$57K |
|
3162
Dakota Gold
DC
$841M
| $113K | ﹤0.01% |
44,500
+5,900
| +15% | +$15.7K |
|
|
FNCB
3163
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $113K | ﹤0.01% |
16,800
+500
| +3% | +$2.85K |
|
|
FAT
3164
DELISTED
FAT Brands
FAT
| $113K | ﹤0.01% |
39,468
-28,345
| -42% | -$99.5K |
|
|
PVLA
3165
Palvella Therapeutics
PVLA
$2.23B
| $113K | ﹤0.01% |
11,471
-6,399
| -36% | -$72.2K |
|
|
WHLM
3166
DELISTED
Wilhelmina International, Inc
WHLM
| $111K | ﹤0.01% |
20,400
+500
| +3% | +$2.61K |
|
3167
DarioHealth
DRIO
$72.9M
| $109K | ﹤0.01% |
4,585
-175
| -4% | -$4.96K |
|
3168
Ovid Therapeutics
OVID
$489M
| $109K | ﹤0.01% |
141,200
-15,600
| -10% | -$43.4K |
|
3169
United States Antimony
UAMY
$799M
| $109K | ﹤0.01% |
322,926
+18,928
| +6% | +$5.28K |
|
3170
Urban One Class A
UONE
$23.3M
| $108K | ﹤0.01% |
5,420
-5,720
| -51% | -$124K |
|
|
NBP
3171
NovaBridge Biosciences American Depositary Shares
NBP
$216M
| $107K | ﹤0.01% |
63,800
| – | – |
|
|
TLIS
3172
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $107K | ﹤0.01% |
12,299
+2,000
| +19% | +$17.7K |
|
3173
Entera Bio
ENTX
$138M
| $106K | ﹤0.01% |
57,600
-17,300
| -23% | -$37.9K |
|
|
ABX
3174
Abacus Global Management
ABX
$833M
| $106K | ﹤0.01% |
+12,200
| New | +$137K |
|
|
VINC
3175
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $105K | ﹤0.01% |
6,506
+436
| +7% | +$10.9K |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.